b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31301289</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>09</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>09</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1872-7786</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>310</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Sep</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Chemico-biological interactions</Title>\n                <ISOAbbreviation>Chem. Biol. Interact.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Application of &quot;macromolecular crowding&quot; in vitro to investigate the naphthoquinones shikonin, naphthazarin and related analogues for the treatment of dermal scars.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>108747</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0009-2797(19)30471-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cbi.2019.108747</ELocationID>\n            <Abstract>\n                <AbstractText>Pathological scarring is an intractable problem for both patients and clinicians. A major obstacle for the development of scar remediation therapies is the paucity of suitable in vivo and in vitro models. The &quot;Scar-in-a-jar&quot; model was previously established by our colleagues based on the principle of &quot;Macromolecular crowding&quot;. This has been demonstrated to be an extracellular matrix-rich in vitro model offering a novel tool for studies related to the extracellular matrix. In the study reported herein, we have optimised this approach to model human dermal fibroblasts derived from hypertrophic tissues. This optimised in vitro model has been found to hold similar properties, such as increased collagen I, interleukins and transforming growth factor beta-1 expression, compared to that observed in hypertrophic scar tissue in vivo. In addition, Shikonin has been previously demonstrated to hold potential as a novel hypertrophic scar treatment due to its apoptosis-inducing property on hypertrophic scar fibroblasts. Other Shikonin analogues have also been reported to hold apoptosis-inducing properties in various cancer cell lines, however, the effects of these analogues on hypertrophic scar-related cells are unknown. We therefore evaluated the effects of Shikonin and its analogues on hypertrophic scar-derived human fibroblasts using the optimised &quot;Macromolecular crowding&quot; model. Our data indicates that Shikonin and Naphthazarin are the most effective molecules compared to related naphthoquinones. The data generated from the study offers a novel in vitro collagen-rich model of hypertrophic scar tissue. It also provides further evidences supporting the use of Shikonin and Naphthazarin as potential treatments for hypertrophic scars.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Fan</LastName>\n                    <ForeName>Chen</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore. Electronic address: Chen.fan@sris.a-star.edu.sg.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lim</LastName>\n                    <ForeName>Lay Keng Priscilla</ForeName>\n                    <Initials>LKP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Loh</LastName>\n                    <ForeName>See Qi</ForeName>\n                    <Initials>SQ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemical and Life Sciences, Singapore Polytechnic, Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ying Lim</LastName>\n                    <ForeName>Kimberley Ying</ForeName>\n                    <Initials>KY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemical and Life Sciences, Singapore Polytechnic, Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Upton</LastName>\n                    <ForeName>Zee</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore; Institute of Medical Biology, A*STAR, Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Leavesley</LastName>\n                    <ForeName>David</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>10</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Ireland</Country>\n            <MedlineTA>Chem Biol Interact</MedlineTA>\n            <NlmUniqueID>0227276</NlmUniqueID>\n            <ISSNLinking>0009-2797</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D009285">Naphthoquinones</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>3IK6592UBW</RegistryNumber>\n                <NameOfSubstance UI="C016101">shikonin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>475-38-7</RegistryNumber>\n                <NameOfSubstance UI="C005503">naphthazarin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9007-34-5</RegistryNumber>\n                <NameOfSubstance UI="D003094">Collagen</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002921" MajorTopicYN="N">Cicatrix</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017439" MajorTopicYN="N">Cicatrix, Hypertrophic</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003094" MajorTopicYN="N">Collagen</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005109" MajorTopicYN="N">Extracellular Matrix</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009285" MajorTopicYN="N">Naphthoquinones</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Hypertrophic scars</Keyword>\n            <Keyword MajorTopicYN="N">Macromolecular crowding</Keyword>\n            <Keyword MajorTopicYN="N">Naphthazarin</Keyword>\n            <Keyword MajorTopicYN="N">Shikonin</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>18</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>9</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31301289</ArticleId>\n            <ArticleId IdType="pii">S0009-2797(19)30471-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.cbi.2019.108747</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'